SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of three InfinityLab Bio LC systems specifically developed to meet the needs of the biopharma ...
Elevating lab efficiency with enhanced automation, connectivity, and sustainability capabilities SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced the release ...
The rapid and efficient separation of complex biomolecules is integral to current drug discovery paradigms. Choosing the appropriate platform for high-resolution analysis of complex N-linked glycans ...
Seamless integration in current infrastructure and smooth method transfer from legacy equipment—for non-disruptive transition to highest productivity and lowest cost of ownership. The InfinityLab ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infinity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results